InvestorsHub Logo
Followers 31
Posts 1587
Boards Moderated 0
Alias Born 01/27/2011

Re: None

Wednesday, 08/30/2017 5:45:14 PM

Wednesday, August 30, 2017 5:45:14 PM

Post# of 7747
On August 30, 2017, CytRx Corporation (the "Company") issued a press release announcing that it has filed a definitive proxy statement with the Securities and Exchange Commission ("SEC") in connection with a special meeting of stockholders to be held on Tuesday, October 17, 2017. The special meeting will be held to authorize the Board of Directors to effect a reverse split of the Company's common stock, if deemed necessa ry, and to reduce the number of authorized shares of common stock by one-half from 250,000,000 to 125,000,000 shares. A reverse stock split may enable the Company to regain compliance with Nasdaq's $1.00 minimum bid price requirement and maintain its listing on the Nasdaq Capital Market.